Application Sponsors
ANDA 215220 | AJANTA PHARMA LTD | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
002 | TABLET; ORAL | 50MG/1000MG | 0 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | SITAGLIPTIN; METFORMIN HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2022-05-31 | STANDARD |
Submissions Property Types
CDER Filings
Accessdata Error
cder:Array
(
[0] => Array
(
[ApplNo] => 215220
[companyName] => Accessdata Error
[docInserts] => ["",""]
[products] => []
[labels] =>
[originalApprovals] => []
[supplements] =>
[actionDate] => 0000-00-00
)
)